Install
Halting the Epidemic of Addiction and Loss Act of 2025
A bill to ensure references to opioid overdose reversal agents in certain grant programs of the Department of Health and Human Services are not limited to naloxone.
- Introduced
- Committee
- Passed Senate
- Passed House
- To President
- Became law
Summary
Halting the Epidemic of Addiction and Loss Act of 2025
This bill requires that, when the Department of Health and Human Services (HHS) issues new regulations or guidance on grant programs addressing opioid use disorders, references to an opioid overdose reversal drug (e.g., naloxone) must broadly include any opioid overdose reversal drug approved by the Food and Drug Administration.
Within one year after the bill’s enactment, HHS must update all references accordingly in regulations or guidance issued prior to the bill’s enactment that are applicable to State Opioid Response Grants, Tribal Opioid Response Grants, or certain other grants relating to substance use disorder prevention.
Summary by the Congressional Research Service, Library of Congress.
Actions
- Jul 17, 2025 Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
- Jul 17, 2025 Introduced in Senate
Congressional and federal records come from official public sources: the House Clerk, the U.S. Senate, GovInfo and the Library of Congress (bill status), the Federal Register, and the congress-legislators project. They are copied on a schedule and may lag the official record by a few hours; the official sources govern. News and coverage counts are drawn from the 4Conservative index and reflect what the press published, not 4Conservative's views. Nothing here is an endorsement of any candidate, party or position. Terms of use.